Nicodrops Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Nicodrops last-minute Real Value cannot be determined due to lack of data. The latest price of Nicodrops is $0.0. Our model forecasts the value of Nicodrops from analyzing the firm fundamentals such as Current Valuation of 2.1 M, price to sales of 5.70 X, and Return On Asset of -0.035 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Nicodrops' price fluctuation is out of control at this time. Calculation of the real value of Nicodrops is based on 3 months time horizon. Increasing Nicodrops' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Nicodrops' intrinsic value may or may not be the same as its current market price of 0.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The intrinsic value of Nicodrops' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nicodrops' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nicodrops helps investors to forecast how Nicodrops stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nicodrops more accurately as focusing exclusively on Nicodrops' fundamentals will not take into account other important factors: Nicodrops Total Value Analysis
Nicodrops is now forecasted to have valuation of 2.1 M with market capitalization of 1.85 K, debt of 2.14 M, and cash on hands of 50.54 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nicodrops fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.1 M | 1.85 K | 2.14 M | 50.54 K |
Nicodrops Investor Information
The company had not issued any dividends in recent years. Nicodrops had 2.25:1 split on the 12th of August 2004. Based on the key indicators related to Nicodrops' liquidity, profitability, solvency, and operating efficiency, Nicodrops is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Nicodrops Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nicodrops has an asset utilization ratio of 16.12 percent. This connotes that the Company is making $0.16 for each dollar of assets. An increasing asset utilization means that Nicodrops is more efficient with each dollar of assets it utilizes for everyday operations.Nicodrops Profitability Analysis
The company reported the previous year's revenue of 326.18 K. Net Loss for the year was (200.8 K) with profit before overhead, payroll, taxes, and interest of 1.32 K.About Nicodrops Valuation
The delisted stock valuation mechanism determines Nicodrops' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Nicodrops based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nicodrops. We calculate exposure to Nicodrops's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nicodrops's related companies.Nicodrops, Inc. develops drug-free, nonnicotine smoking alternative, herbal dietary supplements in the United States. It provides a cough drop form, which is an herbal dietary supplement in a lozenge formula with various natural herbal dietary ingredients that helps reduce the stress associated with not smoking. Nicodrops is traded on OTC Exchange in the United States.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Nicodrops Stock
If you are still planning to invest in Nicodrops check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nicodrops' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |